TARCEVA (erlotinib) Patient Assistance Program

Don’t let cancer treatment costs determine your prognosis. We help eligible patients access Tarceva (erlotinib) for as little as $69.95 per month through available assistance programs.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What is Tarceva Prescription Assistance Program?

The Tarceva Prescription Assistance Program is a manufacturer-sponsored initiative that provides Tarceva at no medication cost to qualifying patients who cannot afford it. The program is available to uninsured and underinsured U.S. residents who meet income and residency requirements. If approved, you receive your medication at no cost.

A cancer diagnosis changes everything — your health, your priorities, your ability to work, and your financial security. When your oncologist prescribes an EGFR inhibitor as part of your cancer treatment, cost should never be the reason you delay or forgo therapy that could extend your life. Whether you need brand-name Tarceva or the more affordable generic erlotinib, AffordMyPrescriptions ensures you get the treatment your doctor has prescribed

For a flat $69.95 per month, our Patient Advocates identify the most affordable pathway and manage the entire enrollment process.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens

~$150.00

Save ~$80/mo
CVS Pharmacy

~$160.00

Save ~$90/mo

Walmart

~$130.00

Save ~$60/mo

Costco

~$120.00

Save ~$50/mo

Kroger

~$92.00

Save ~$22/mo

*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Tarceva Prescription Program?

When you’re battling lung cancer or pancreatic cancer, navigating the financial complexity of specialty oncology medications should be the least of your concerns. Yet the reality involves insurance prior authorizations, specialty pharmacy coordination, formulary coverage determinations, and financial assistance applications — all while you’re managing the physical and emotional demands of cancer treatment.

Our trained Patient Advocates specialize in oncology medication access and manage every administrative detail on your behalf. From the moment you enroll, your advocate determines whether brand-name Tarceva or generic erlotinib is the right fit for your situation, prepares your application, coordinates with your oncologist, and tracks your status through every stage. When refills are due, they coordinate proactively so your cancer treatment is never interrupted.

Our pricing is simple and predictable: $69.95 per month — every month. While the medication itself is provided at no cost through the manufacturer’s program (or at the lowest available coupon price for the generic), our monthly fee covers all advocacy and program management. If we’re unable to secure access, you won’t be charged.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:

Limitations of Coupons

  • Generic erlotinib coupons fluctuate $92–$223/month
  • Cards expire and require constant renewal

  • Brand Tarceva coupons still cost $2,874+/month
  • Specialty pharmacy network may limit applicability
  • Insurance prior authorization often required

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price

  • No expiration — continuous access as long as you qualify
  • Brand-name medication supplied directly from the manufacturer

  • We manage all paperwork, refills, and annual renewals
  • Medicare Part D patients accepted

DO YOU QUALIFY?

Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Recent financial changes from a cancer diagnosis often qualify patients for assistance.

Understanding Tarceva:

Tarceva (erlotinib) is a once-daily prescription oral tablet used to treat metastatic non-small cell lung cancer (NSCLC) and locally advanced, unresectable, or metastatic pancreatic cancer (in combination with gemcitabine). It is a targeted cancer therapy that specifically blocks the epidermal growth factor receptor (EGFR), a protein that drives cancer cell growth. Available in 25 mg, 100 mg, and 150 mg tablets


How It Works:

Cancer cells rely on the EGFR protein to receive growth signals that tell them to divide. In many cancers, this protein is overactive or mutated to stay “on.” Tarceva enters the cell and binds to the internal part of the EGFR protein, jamming the signal. This forces cancer cells to stop dividing and often leads to programmed cell death.

Form and Use:

This medication comes in 25 mg, 100 mg, and 150 mg tablets, with the specific dose determined by an oncologist. It must be taken once daily on an empty stomach, either one hour before or two hours after a meal. This timing is critical because food significantly increases absorption and can change how well the drug works.

Generic Availability:

Generic erlotinib is FDA-approved and clinically equivalent to the brand-name version but costs significantly less. While Tarceva can cost up to $8,909 per month, the generic is available for as little as $92 to $223 with coupons. For those who specifically need the brand name, assistance programs like AffordMyPrescriptions can provide it at no medication cost.

Warnings:

Tarceva can cause serious side effects, including interstitial lung disease, gastrointestinal perforation, and severe skin reactions. More common side effects include rash, diarrhea, fatigue, and loss of appetite. It is essential to discuss all medical conditions with a healthcare provider before starting treatment and to report any new symptoms immediately..

FAQ (Frequently Asked Questions)

How Much Does Tarceva/Erlotinib Cost Without Insurance?

Brand-name Tarceva costs approximately $2,874–$8,909 per month depending on dose. Generic erlotinib is available for as little as $92–$223 per month with coupons. Through AffordMyPrescriptions, qualifying patients can access brand Tarceva at no medication cost, or we’ll help you find the lowest coupon price for generic erlotinib — our $69.95 monthly fee covers advocacy.

Yes. The Synthroid supplied through the Patient Assistance Program is the same FDA-approved levothyroxine sodium medication dispensed at retail pharmacies, supplied directly from the manufacturer.

Levothyroxine has a narrow therapeutic index — small differences between formulations can affect your thyroid levels. Many endocrinologists specifically prescribe brand-name Synthroid and recommend patients remain on the same formulation once their thyroid levels are stable. If your doctor allows generic, it’s dramatically more affordable. But if your doctor requires the brand, the PAP or delivery program provides the most affordable access.

Yes. Medicare Part D patients may qualify for the Patient Assistance Program. As of 2026, Medicare Part D plans also have a $2,100 annual out-of-pocket cap. Our advocates can help you evaluate the best pathway.

Both target EGFR, but they are different generations. Tagrisso (osimertinib) is a third-generation EGFR inhibitor that targets both original EGFR mutations and the T790M resistance mutation. Tagrisso also crosses the blood-brain barrier more effectively. Current guidelines recommend osimertinib as first-line therapy when accessible.

Our Patient Advocates will immediately explore every alternative — including generic erlotinib at coupon prices ($92–$223/month), GoodRx and SingleCare discounts, independent co-pay assistance foundations (PAN Foundation, HealthWell Foundation, CancerCare), insurance prior authorization appeals, Tagrisso (osimertinib) as an alternative EGFR inhibitor, and clinical trial enrollment.

Take Control of Your Medication Costs

If you are struggling with the high cost of Tarceva, our team may be able to help you access assistance programs designed to make medications more affordable. Check your eligibility today and take the first step toward reducing your prescription costs.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process